Isis Pharmaceuticals Inc
(NASDAQ: ISIS)
+0.50
+2.48%
Isis Pharmaceuticals Inc, a mid-cap growth company in the health care sector, is expected to match the market over the next six months with above average risk.
10 is the best possible rating.
The StockScouter measure of relative price change and consistency is very high. Very positive
Earnings growth in the past year has accelerated rapidly compared to earnings growth in the past three years. Positive
ConThe most recent quarterly earnings report was significantly lower than analysts' consensus forecast. Negative
The price-to-earnings multiple is a negative number. No effect
The most recent quarterly earnings report was significantly lower than analysts' consensus forecast. Negative
Earnings growth in the past year has accelerated rapidly compared to earnings growth in the past three years. Positive
One or more analysts has significantly increased quarterly earnings estimates for ISIS. Positive
An executive, director or major shareholder sold a small number of shares recently. Neutral
Shares are being heavily sold by financial institutions. Neutral for a large company like ISIS
The price-to-earnings multiple is a negative number. No effect
The price-to-sales multiple is significantly higher than the average for all stocks in the StockScouter universe. Very positive for a medium- to large-sized company like ISIS
The ratio of ISIS's price-to-earnings multiple to its five-year growth rate is unavailable or inconsistent.
The StockScouter measure of relative price change and consistency is very high. Very positive
Previous day's closing price for ISIS was slightly above its 50-day moving average. Positive
data provided by Verus Analytics
Learn more about the StockScouter rating system.
Page generated 5/19/2013 3:50 AM ET
Copyright © 2013 Microsoft. All rights reserved.
Quotes are real-time for NASDAQ, NYSE and AMEX. See delay times for other exchanges.
Fundamental company data and historical chart data provided by Thomson Reuters (click for restrictions). Real-time quotes provided by BATS Exchange. Real-time index quotes and delayed quotes supplied by Interactive Data Real-Time Services. Fund summary, fund performance and dividend data provided by Morningstar Inc. Analyst recommendations data provided by Zacks Investment Research. StockScouter data provided by Verus Analytics. IPO data provided by Hoover's Inc. Index membership data provided by SIX Financial Information.
Japanese stock price data provided by Nomura Research Institute Ltd.; quotes delayed 20 minutes. Canadian fund data provided by CANNEX Financial Exchanges Ltd.
